North Dakota Opioid Settlement Fund Grant
Grants for opioid use prevention and overdose prevention in North Dakota, including best practices relating to fentanyl drug overdose and workforce development activities. Geographic coverage: North Dakota -- North Dakota Department of Health (Source: Emergency services funding opportunities via the Rural Assistance Center)
Source: Emergency services funding opportunities via the Rural Assistance Center - December 15, 2023 Category: Rural Health Source Type: funding
Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand adolescent illicit fentanyl use and overdose patterns among youth at high risk for overdose. Research studies should identify targets for overdose prevention and substance use disorder (SUD) treatment and recovery. Research studies may use a variety of approaches (e.g., leveraging existing data sources, survey research, social network analysis, new methods development, feasibility research). Outcomes of interest include but are n...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2023 Category: Research Source Type: funding
Preventing Youth Overdose: Treatment, Recovery, Education, Awareness, and Training
Grants to increase services across the spectrum of prevention, treatment, and recovery for youth and young adults with, or at risk for, opioid use disorder and/or co-occurring disorders by supporting local efforts to raise awareness about fentanyl, improve access to treatment with medications, and to support youth with their treatment and recovery. Tribal and rural populations are a program priority. Geographic coverage: Nationwide -- Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 2, 2023 Category: American Health Source Type: funding
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Optional)
Funding Opportunity RFA-DA-23-045 from the NIH Guide for Grants and Contracts. The need to rapidly develop methods to assess the prevalence / health impact of emerging illicit drugs has never been greater. Illicit chemists are marketing potent drugs of abuse taken from deep wells of scientific and patent literature, which we can expect to continue to yield new drugs for many years. Over the last few years, fentanyl/fentalogs (fentanyl-related opioids) have flooded the illicit opioid market, which has complicated patient stabilization / harm reduction, and caused mortality rates to skyrocket. Even understanding the drugs...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2022 Category: Research Source Type: funding
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
Funding Opportunity RFA-DA-23-008 from the NIH Guide for Grants and Contracts. Stimulant use has been increasing among opioid users since 2016, based on overdose data and this makes control of the opioid epidemic more difficult, as it occurs in addition to the continuing influx of fentanyl and related compounds. Stimulant/opioid users present unfamiliar clinical issues to providers and experienced providers often find polysubstance users less motivated to address stimulant use. Stimulant use also has continued to account for a substantial fraction of HIV cases among gay men and other MSM. Much of this use is problematic...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 16, 2022 Category: Research Source Type: funding
Notice of clarification in RFA-DA-22-022, " Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)"
Notice NOT-DA-21-083 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2021 Category: Research Source Type: funding
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-DA-22-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to understand and respond to new challenges in the treatment of drug addiction and overdose, introduced by the now widespread presence of fentanyl and its analogs (fentanils) in illicit drug supplies. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 12, 2021 Category: Research Source Type: funding
California Overdose Prevention Network Accelerator 3.0 Program
A 12-month training, coaching, and networking program for coalitions in California to develop and expand strategies to address overdose rates from fentanyl, methamphetamines, and other drugs. Coalitions from rural areas and other overdose "hot spots" are encouraged to apply. Geographic coverage: California -- California Overdose Prevention Network (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 26, 2021 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements for research on fentanyl and derivatives
Notice NOT-DA-21-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 25, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and Pharmacology
Notice NOT-DA-21-033 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 24, 2021 Category: Research Source Type: funding
Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality
Funding Opportunity Number: CDC-RFA-CE16-1608 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.136Eligible Applicants State governmentsAgency Name: HHS-CDC-NCIPCClosing Date: Jun 27, 2016Award Ceiling: $775,000Expected Number of Awards: 11Creation Date: Apr 25, 2016Funding Opportunity Description: Overdose deaths involving opioids in the US have quadrupled since 1999, with 28,647 fatalities in 2014. Research indicates two distinct but interrelated trends: a fifteen-year increase in overdose deaths i...
Source: Grants.gov - April 26, 2016 Category: Research Tags: Health Source Type: funding
